Sophie Branchereau Selected Research

Sophie Branchereau Research Topics

Disease

15	Neoplasms (Cancer) 04/2024 - 11/2002
14	Hepatoblastoma 03/2024 - 12/2008
4	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 11/2002
4	Biliary Atresia 01/2023 - 02/2005
3	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2018
2	Liver Diseases (Liver Disease) 01/2022 - 01/2015
2	Liver Neoplasms (Liver Cancer) 10/2021 - 12/2008
2	Margins of Excision 01/2019 - 03/2010
2	Budd-Chiari Syndrome (Budd Chiari Syndrome) 01/2018 - 02/2015
2	Vascular Malformations 01/2018 - 09/2010
2	Necrosis 10/2016 - 02/2015
2	Fibrosis (Cirrhosis) 10/2016 - 01/2015
2	Rupture 02/2015 - 08/2013
2	progressive familial intrahepatic 1 Cholestasis 01/2015 - 05/2010
2	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2013 - 11/2003
1	Thrombosis (Thrombus) 04/2024
1	Residual Neoplasm 01/2024
1	Esophageal atresia with or without tracheoesophageal fistula 04/2023
1	Constipation 01/2022
1	COVID-19 10/2020
1	Portal Hypertension 03/2019
1	Tertiary Lymphoid Structures 01/2019
1	Pneumothorax 01/2019
1	Alagille Syndrome (Alagille-Watson Syndrome) 01/2017
1	Hemorrhage 02/2015
1	Sarcoma (Soft Tissue Sarcoma) 02/2015
1	Metabolic Diseases (Metabolic Disease) 01/2015
1	Hepatolenticular Degeneration (Wilson's Disease) 03/2014
1	Pathologic Complete Response 08/2013
1	Fanconi Anemia (Fanconi's Anemia) 01/2013
1	Focal Nodular Hyperplasia 01/2013
1	Intussusception 12/2012
1	Fistula 09/2010
1	Liver Failure 05/2010
1	Cholelithiasis 05/2010
1	Endocarditis 08/2009
1	Aspergillosis 08/2009
1	Rhabdomyosarcoma 01/2009
1	Acute Liver Failure (Fulminant Hepatic Failure) 06/2008
1	Infections 06/2008
1	Type 3 Maturity-Onset Diabetes of the Young 11/2003

Drug/Important Bio-Agent (IBA)

5	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 08/2013
3	beta CateninIBA 01/2017 - 11/2002
2	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 06/2008
2	CateninsIBA 02/2024 - 01/2017
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2019 - 10/2016
1	SolutionsIBA 03/2024
1	MethyltransferasesIBA 02/2024
1	CytokinesIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2024
1	Cyclin-Dependent Kinase 9IBA 09/2023
1	Choline KinaseIBA 01/2020
1	BI 6727IBA 11/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	IntegrinsIBA 01/2018
1	VimentinIBA 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 10/2016
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2016
1	LipidsIBA 01/2015
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2015
1	Fetal Proteins (Fetoprotein)IBA 08/2013
1	AndrogensIBA 01/2013
1	SerpinsIBA 05/2012
1	TransferasesIBA 05/2010
1	Alanine Transaminase (SGPT)IBA 05/2010
1	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 05/2010
1	Bile Acids and Salts (Bile Acids)IBA 05/2010
1	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 11/2003
1	Interleukin-8 (Interleukin 8)IBA 11/2002

Therapy/Procedure

14	Liver Transplantation 01/2023 - 02/2005
10	Drug Therapy (Chemotherapy) 10/2021 - 12/2011
8	Therapeutics 02/2024 - 08/2009
4	Neoadjuvant Therapy 04/2024 - 02/2015
3	Hepatectomy 01/2024 - 03/2010
3	Radiotherapy 01/2019 - 01/2009
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2018 - 09/2010
2	Transplantation 10/2020 - 01/2015
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2024
1	Length of Stay 04/2023
1	Parenteral Nutrition 04/2023
1	Operative Surgical Procedures 01/2022
1	Hematopoietic Stem Cell Transplantation 10/2020
1	Organ Transplantation 10/2020
1	Hepatic Portoenterostomy 03/2019
1	Metastasectomy 01/2019
1	Radiofrequency Ablation 01/2019
1	Chest Tubes (Chest Tube) 01/2019
1	Aftercare (After-Treatment) 10/2016
1	Roux-en-Y Anastomosis (Anastomosis, Roux en Y) 02/2015
1	Enema (Enemas) 12/2012
1	General Anesthesia 12/2012
1	Prostatectomy (Retropubic Prostatectomy) 01/2009
1	Cystectomy 01/2009
1	Brachytherapy 01/2009